Ledger.Open graph →
SEC Form D · filed December 28, 2022

Aro Biotherapeutics Co

Offering
$100.0M
Sold
$24.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Philadelphia, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Christopher B. Mirabelli · Philadelphia, PADirectorSusan B. Dillon · Philadelphia, PAExec · DirectorScott B. Greenberg · Philadelphia, PAExecMarten B. Steen · Philadelphia, PADirectorBruce B. Peacock · Philadelphia, PADirectorElizabeth B. Anderson · Philadelphia, PADirectorMark B. Laurenzi · Philadelphia, PAExecKevin B. Raidy · Philadelphia, PADirectorMittie B. Doyle · Philadelphia, PAExecKaryn B. O'Neil · Philadelphia, PAExec · DirectorDaniel B. Janse · Philadelphia, PADirectorChristopher B. Mirabelli · Philadelphia, PADirectorSusan B. Dillon · Philadelphia, PAExec · DirectorScott B. Greenberg · Philadelphia, PAExecKaryn B. O'Neil · Philadelphia, PAExec · DirectorMarten B. Steen · Philadelphia, PADirectorBruce B. Peacock · Philadelphia, PADirectorElizabeth B. Anderson · Philadelphia, PADirectorDaniel B. Janse · Philadelphia, PADirectorMark B. Laurenzi · Philadelphia, PAExecKevin B. Raidy · Philadelphia, PADirectorMittie B. Doyle · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗